Pernicious effectors in burns

Burns

Volumn 34, Issue 1 SUPPL., 2008, Pages

  Allgöwer, Martin ^a   Schoenenberger, Guido A ^a   Sparkes, Brian G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTIINFECTIVE AGENT; CERIUM NITRATE; ENDOTOXIN; FLAMMACERIUM; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1; SILVER NITRATE; SULFADIAZINE SILVER;

ANTIMICROBIAL THERAPY; ARTICLE; BURN; CELL DEATH; CHEMOLUMINESCENCE; CLINICAL TRIAL; DERMIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; EXPERIMENTAL MOUSE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNORADIOMETRIC ASSAY; IMMUNOSUPPRESSIVE TREATMENT; MORTALITY; NONHUMAN; PHAGOCYTOSIS; PROTEIN LIPID INTERACTION; SEPSIS; SKIN TOXICITY; SURVIVAL RATE; TISSUE HOMOGENATE; TRANSMISSION ELECTRON MICROSCOPY;

EID: 47049110631     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2008.05.012     Document Type: Article

References (168)

1. Burke J.F. Burn treatment's evolution in the 20th century (centennial article). J Am Coll Surg 200 (2005) 152-153
2. Montgomery B.J. Consensus for treatment of "the sickest patients you'll ever see". JAMA 241 (1979) 345-356
3. Pruitt B.A. Forces and factors influencing trauma care: 1983 AAST presidential address. J Trauma 24 (1984) 463-470
4. Munster A.M. Alteration of the immune system in burns and implications for therapy. Eur J Pediatr Surg 4 (1994) 231-242
5. Bardeen C.R. A review of the pathology of superficial burns. Johns Hopkins Hospital Reports 7 (1898) 137-145
6. Cumin W. Internal pathological effects of burns. Edin Med Surg J 19 (1823) 337-342
7. Avdakoff V. Pathological modification of tissue by burns. St. Petersburg Med Vestnik 16 (1876) 4-19
8. Wilms M. Studien zur Pathologie der Verbrennung. Mitt Grenzgeb Med U. Chir 8 (1901) 393-399
9. Wells B.D. The treatment of electric burns by immediate resection and skin graft. Ann Surg 90 (1929) 1069-1077
10. Phillips A.W., and Cope O. Burn therapy. I: Concealed progress due to a shifting battlefront. Ann Surg 152 (1960) 767-776
11. Arturson G. The Los Alfaques disaster: a boiling liquid, expanding vapour explosion. Burns 7 (1981) 233-251
12. Baxter C.R. The current status of burn research. J Trauma 14 (1974) 1
13. Prinzmetal M. Demonstration of two types of burn shock. Surgery 16 (1944) 906-913
14. Allgower M., Burri C., Gruber U.L., and Nagel G. Toxicity of burned mouse skin in relation to burn temperature. Surg Forum 14 (1963) 37-39
15. Allgower M, Schoenenberger GA. Unsolved problems of severely burned patients. In: Toxic factors in burns. University of London: European Research Office; 1976, p. 4-7.
16. Allgower M., Burri C., Cueni L., et al. Study of burn toxins. Ann N Y Acad Sci 150 (1968) 807-815
17. Schoenenberger G.A. Burn toxins isolated from mouse and human skin. Monogr Allergy 9 (1975) 72-139
18. Allgower M., Cueni L.B., Stadtler K., and Schoenenberger G.A. Burn toxin in mouse skin. J Trauma 13 (1973) 95-111
19. Schoenenberger G.A., Bauer U.R., Cueni L.B., Eppenberger U., and Allgower M. Isolation and characterization of a cutaneous lipoprotein with lethal effects produced by thermal energy in mouse skin. Biochem Biophys Res Commun 42 (1971) 975-982
20. Schoenenberger G.A., Cueni L.B., Bauer V., Eppenberger V., and Allgower M. Isolation and characterization of a toxic lipid-protein complex formed in mouse skin by controlled thermal energy. Biochim Biophys Acta 263 (1972) 149-163
21. Schoenenberger G.A., Bauer V., Cueni L.B., Eppenberger V., Stadtler K., and Allgower M. Physical, chemical and biological properties of a specific toxic lipid-protein complex formed in thermally altered mouse skin. Biochim Biophys Acta 263 (1972) 164-177
22. Schoenenberger GA, Allgower M. Physico-chemical analysis of the toxic lipid-protein complex as compared to its naturally occurring precursor. In: Toxic factors in burns. University of London: European Research Office; 1976, p. 79-89.
23. Schoenenberger GA. Immunological evidences of the occurrence of a specific antitoxic IgG-fraction in serum of severely burned patients. In: Koslowski L, Schmidt K, R. Hettich R, editors. Burn injuries, local treatment, toxic factors, infusion therapy. Stuttgart: Schattauer Verlag; 1979, p. 101-11.
24. Kremer B, Allgower M, Scholmerich J, Schoenenberger GA. Burn toxin. In: Ninneman JL, editor. The immune consequences of thermal injury. Baltimore/London: Williams & Wilkins; 1981, p. 90-118.
25. Schoenenberger G.A., Burkhardt F., Kalberer F., et al. Experimental evidence for a signifi cant impairment of host defense for Gram-negative organisms by a specific cutaneous toxin produced by severe burn injuries. Surg Gyn Obstet 141 (1975) 555-561
26. Kremer B., Allgower M., Scheidegger A.M., et al. Toxinspecifi c ultrastructural alterations of the mouse liver after burn injuries and the possibility of a specific antitoxic therapy. Scand J Plast Reconstr Surg 13 (1979) 217-222
27. Scholmerich J., Kremer B., Richter I.E., Schmidt K., Setyadharma H., and Schoenenberger G.A. Effect of cutaneous human or mouse burn toxin on the metabolic function of isolated liver cells. Scand J Plast Reconstr Surg 13 (1979) 223-230
28. Kremer B., Allgower M., Graf M., Schmidt K.H., Schoelmerich J., and Schoenenberger G.A. The present status of research in burn toxins. Intensive Care Med 7 (1981) 77-87
29. Allgower M. Anämie. In: Allgower M, Siegrist J, editors. Verbrennungen. Pathophysiologie, pathologie, klinik, therapie. Berlin: Springer Verlag; 1957, p. 88-91.
30. Loebl E.C., Baxter C.R., and Curreri W.P. The mechanism of erythrocyte destruction in the early post burn period. Ann Surg 178 (1973) 681-686
31. Loebl E.C., Marvin J.A., Curreri W.P., and Baxter C.R. Erythrocyte survival following thermal injury. J Surg Res 16 (1974) 96-101
32. Allgower M., Schoenenberger G.A., and Sparkes B.G. Burning the largest immune organ. Burns 21 S1 (1995) S7-S47
33. Sparkes B.G., Monge G., Marshall S., Peters W., Allgower M., and Schoenenberger G. Plasma levels of cutaneous burn toxin and lipid peroxides in thermal injury. Burns 16 (1990) 118-122
34. Alexander JW, Stinnett JD, Ogle CK Alterations in neutrophil function. In: Ninneman JL, editor. The immune consequences of thermal injury. Baltimore MD: Williams & Wilkins; 1981, p. 21-35.
35. Buffone V., Meakins J.L., and Christou N.V. Neutrophil function in surgical patients. Arch Surg 119 (1984) 39-42
36. Miller C.L. Alterations in macrophage function following thermal injury. In: Ninneman JL, editor. The immune consequences of thermal injury. Baltimore MD: Williams & Wilkins; 1981, p. 49-65.
37. Heberer M., Allgower M., Durig M., Beutler P., Hasler P., and Schoenenberger G.A. Chemoluminescence of phagocytic cells following incubation of whole blood with human burn toxin. Eur Surg Res 14 (1982) 107-108
38. Allgower M., Graf M., and Hasler P. Evidence of possible involvement of a cutaneous burn toxin in the late burn disease/mortality. Bull Clin Rev Burn Inj 1 (1984) 27-29
39. Dobke M.K., Deitch E.A., Harnar T.J., and Baxter C.R. Oxidative activity of polymorphonuclear leukocytes after thermal injury. Arch Surg 124 (1989) 856-859
40. Howes R.M., Allen R.C., Su C.T., and Hoopes J.E. Altered polymorphonuclear leukocyte bioenergetics in patients with thermal injury. Surg Forum 27 (1976) 558-562
41. Alexander J.W., and Wixon D. Neutrophil dysfunction of polymorphonuclear leukocytes in patients with burns and other trauma. Surg Gynecol Obstet 130 (1970) 431-439
42. Grogan J.B. Altered neutrophil phagocytic function in burn patients. J Trauma 16 (1976) 734-740
43. Burri C., and Allgower M. Die Wirkung verbrannter, steriler Haut auf normale und RES-blocierte Mause. Z Ges Exp Med 138 (1964) 378-382
44. Sultzer B.M. Genetic control of host responses to endotoxin. Infect Immun 5 (1972) 152-158
45. Sparkes B.G., Gyorkos J., Gorczynski R., and Brock A. Comparison of endotoxins and cutaneous burn toxin as immunosuppressants. Burns 16 (1990) 123-127
46. Bull JP. Revised analysis of mortality due to burns. Lancet 1971;ii:1133-4.
47. Hiebert J.M., McGough M., and Roeheaver G. The influence of catabolism on immunocompetence in burned patients. Surgery 86 (1979) 242-247
48. Peterson VM, Rundus C. In vitro granulopoietic defects modulated by cutaneous burn toxin. American Burn Association 17th Annual Meeting, 1985, Abstract 69.
49. Sparkes BG, Teodorczyk-Injeyan J, Peters W, Falk R. Mediators affecting IL2 function in burn immunosuppression. In: Paubert-Braquet M, et al., editors. Lipid mediators in immunology of shock: burns and sepsis. New York: Plenum Press; 1987, p. 337-48.
50. Edelson R.L., and Fink J.M. The immunologic function of skin. Sci Am 252 (1985) 46-136
51. Dupuy P., Heslan M., and Fraitag S. T-cell receptor-γ/δ-bearing lymphocytes in normal and infl ammatory human skin. J Invest Dermatol 94 (1990) 764-770
52. Basham T.Y., Nickoloff B.J., and Merigan T.C. Recombinant gamma interferon differentially regulated Class II antigen expression and biosynthesis on cultured human keratinocytes. J Interfer Res 5 (1985) 23-31
53. Nickoloff BJ, Lewinsohn DM, Butcher EC, Krensky AM, Clayberger C. Recombinant gamma interferon increases the binding of peripheral blood mononuclear leukocytes and a leu 3+ T lymphocyte clone to cultured keratinocytes and to a malignant cutaneous squamous carcinoma cell line that is blocked by antibody against the LFA 1 molecule. J Invest Dermatol 1988; 90:17-22.
54. Kupper T.S. Interleukin 1 and other human keratinocyte cytokines: molecular and functional characterization. Adv Dermatol 3 (1988) 293-299
55. Katz S.I., Tamaki K., and Sachs D.H. Epidermal Langerhans cells are derived from cells originating in the bone marrow. Nature 282 (1979) 324
56. Aberer W., Schuler G., Stingl G., Honigsman H., and Wolff K. Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol 76 (1981) 202-210
57. Schmitt D. La présentation antigénique au niveau de la peau. Rôle des cellules de Langerhans. Ann Dermatol Vénéréol 117 (1990) 405-413
58. Branch C.D., Wilkins C.F., and Ross F.P. The coagulum contact method of skin grafting in the treatment of burns and wounds. Surgery 19 (1945) 460-465
59. Ninneman J.L., and Stein M.D. Suppression of in vitro lymphocyte response by "burn toxin"-isolates from thermally injured skin. Immunol Lett 2 (1981) 339-342
60. Ninneman J.L., and Ozkan A.N. Circulating toxins in human disease: a viable concept?. Ann Plast Surg 14 (1985) 155-157
61. Ninneman J.L., and Stein M.D. Bacterial endotoxin and the generation of suppressor T cells following thermal injury. J Trauma 20 (1980) 959-964
62. Gery I, Davies P. Immunoregulatory products of macrophages. In: Cohen S, Pick J, Oppenheim JJ, editors. Biology of the lymphokines. New York: Academic Press; 1979, p. 347-67.
63. Hansbrough J.F., Zapata-Sirvent R., and Hoyt D. Postburn immune suppression: an infl ammatory response to the burn wound?. J Trauma 30 (1990) 671-675
64. Sparkes B.G. Influence of burn-induced lipid-proteincomplex on IL2 secretion by PBMC in vitro. Burns 17 (1991) 129-135
65. Teodorczyk-Injeyan J., Sparkes B.G., Peters W., and Falk R. Lymphoproliferative response to phytohemagglutinin in the burn patient-no paradigm in vitro. J Burn Care Rehabil 7 (1986) 112-116
66. Wood J., Rodrick M., O'Mahony J., et al. Inadequate interleukin 2 production. A fundamental immunological deficiency in patients with major burns. Ann Surg 200 (1984) 311-319
67. Teodorczyk-Injeyan J., Sparkes B.G., Mills G.B., Peters W., and Falk R. Impairment of T cell activation in burn patients: a possible mechanism of thermal injury-induced immunosuppression. Clin Exp Immunol 65 (1986) 570-581
68. Teodorczyk-Injeyan J., Sparkes B.G., Mills G.B., Peters W., and Falk R. Impaired expression of interleukin 2 receptor (IL 2R) in the immunosuppressed burn patient. Reversal by exogenous IL 2. J Trauma 27 (1987) 180-187
69. Teodorczyk-Injeyan J., Sparkes B., Mills G., Peters W., and Falk R. Increase of serum interleukin 2 receptor level in thermally injured patients. Clin Immunol Immunopathol. 51 (1989) 205-215
70. Teodorczyk-Injeyan J., Sparkes B.G., and Peters W. Serum interleukin 2 receptor as a possible mediator of post-burn immunosuppression. J Burn Care Rehabil 10 (1989) 112-118
71. Teodorczyk-Injeyan J., Sparkes B.G., and Peters W. Soluble interleukin 2-receptor α secretion is related to altered interleukin 2 production in thermally injured patients. Burns 17 (1991) 290-295
72. Teodorczyk-Injeyan J., Sparkes B.G., Mills G., and Peters W. Immunosuppression follows systemic T lymphocyte activation in the burn patient. Clin Exp Immunol 85 (1991) 515-518
73. Teodorczyk-Injeyan J., Sparkes B.G., Falk R., Peters W., and Mills G. Interleukin-2 secretion and transmembrane signalling in burned patients. J Trauma 28 (1988) 152-157
74. Liu X.-S., Yang Z.-C., Luo Z.-H., and Li A. Clinical significance of the change of blood monocytic interleukin-1 production in vitro in severely burned patients. Burns 20 (1994) 302-306
75. Monge G., Sparkes B.G., Allgower M., and Schoenenberger G.A. Influence of burn-induced lipid-protein complex on IL1 secretion by PBMC in vitro. Burns 17 (1991) 269-275
76. Drost A., Burleson D., Cioffi W., Jordan B., Mason A.J., and Pruitt B. Plasma cytokines following thermal injury and their relationship with mortality, burn size and time postburn. J Trauma 35 (1993) 335
77. Bone R.C. Defi nitions for sepsis and organ failure. JAMA 270 (1993) 939
78. Demling R.H., and Lalonde C. Early burn excision attenuates the postburn lung and systemic response to endotoxin. Surgery 108 (1990) 28-35
79. Golstein P., Ojcius D.M., and Young J.D.-E. Cell death mechanisms and the immune system. Immunol Rev 121 (1991) 29-65
80. Mountz J.D., Zhou T., Wu J., Wang W., Su X., and Cheng J. Regulation of apoptosis in immune cells. J Clin Immunol 15 (1995) 1-16
81. Russel J.H., White C.L., Loh D.Y., and Meleedy-Rey P. Receptorstimulated death pathway is opened by antigen in mature T cells. Proc Natl Acad Sci U S A 88 (1991) 2151-2155
82. Lenardo M.J. Interleukin 2 programs mouse αβ T lymphocytes for apoptosis. Nature 353 (1991) 858-861
83. Sellins K.S., and Cohen J.J. Hyperthermia induces apoptosis in thymocytes. Radiat Res 126 (1991) 88-95
84. Baxter G.D., and Lavin M.F. Specific protein dephosphorylation in apoptosis induced by ionizing radiation and heat shock in human lymphoid tumor lines. J Immunol 148 (1992) 1949-1954
85. Migliorati G., Nicoletti I., Crocicchio F., Pagliacci C., D'Adamio F., and Riccardi C. Heat shock induces apoptosis in mouse thymocytes and protects them from glucocorticoid-induced cell death. Cell Immunol 143 (1992) 348-356
86. Teodorczyk-Injeyan J.A., Cembrzynska-Nowak M.C., Lalani S., Peters W.J., and Mills G.B. Immune deficiency following thermal trauma is associated with apoptotic cell death. J Clin Immunol 15 (1995) 318-328
87. Peter M.E., and Krammer P.H. Mechanisms of CD95 (APO-1/Fas)- mediated apoptosis. Curr Opin Immunol 10 (1998) 545-551
88. Tschopp J., Irmler M., and Thome M. Inhibition of Fas death signals by FLIPs. Curr Opin Immunol 10 (1998) 552-558
89. Chinnaiyan A.M., O'Rourke K., Tewari M., and Dixit V.M. FADD a novel death domain-containing protein, interacts with death domain of Fas and initiates apoptosis. Cell 81 (1995) 505-512
90. Han Z., Bhalla K., Pantazis P., Hendrickson E.A., and Wyche J.H. Cif (cytochromec efflux-inducing factor) activity is regulated by Bcl-2 and caspases and correlates with the activation of Bid. Mol Cell Biol 19 (1999) 1381-1389
91. Dallaporta B., Hirsch T., Susin S.A., et al. Potassium leakage during the apoptotic degradation phase. J Immunol 1600 (1998) 5605-5615
92. Susin S.A., Zamzami N., Castedo M., et al. The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis. J Exp Med 186 (1997) 25-37
93. Bradham C.A., Qian T., Streetz K., Trautwein C., Brenner D.A., and Lemasters J.J. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome release. Mol Cell Biol 18 (1998) 6353-6364
94. Cohen J.J. Apoptosis. Immunology Today 14 (1993) 126-130
95. Border JR, Bone LB, Steinberg SM, Rodriguez JL, Hassett JM, Leutenegger AF. Metabolic response to trauma and sepsis. In: Border JR, et al., editors. Blunt multiple trauma. New York and Basel: Marcel Dekker; 1990, p. 191-258.
96. Winchurch R.A., Thupari J.N., and Munster A.M. Endotoxemia in burn patients. Levels of circulating endotoxins are related to burn size. Surgery 102 (1987) 808-812
97. Ziegler T.R., Smith R.J., O'Dwyer S.T., Demling R.H., and Wilmore D.W. Increased intestinal permeability associated with infection in burn patients. Arch Surg 123 (1988) 1313-1319
98. Stuntz M.E., Witte M.H., and Witte C.L. Effect of interleukin-2 on microvascular liquid and protein transport in the rat small intestine. Lymphology 23 (1990) 149-154
99. Rosenstein M., Ettinghausen S.E., and Rosenberg S.E. Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin-2. J Immunol 137 (1986) 1735-1742
100. Demling R.H. Burns. N Engl J Med 313 (1985) 1389-1398
101. Demling R.H., and Lalonde C. Identification and modifications of the pulmonary and systemic inflammatory and biochemical changes caused by a skin burn. J Trauma 30 (1990) S57-S62
102. Deitch E.A., and Berg R.D. Endotoxin but not malnutrition promotes bacterial translocation of the gut flora in burned mice. J Trauma 27 (1987) 161-166
103. Yao T.-M., Yu Y., Sheng C.-Y., et al. Role of gut-derived endotoxaemia and bacterial translocation in rats after thermal injury: effects of selective decontamination of the digestive tract. Burns 21 (1995) 580-585
104. Jones W.G., Barber A.E., Minei J.P., Fahey T.J., Shires G.T.I., and Shires G.T. Antibiotic prophylaxis diminishes bacterial translocation but not mortality in experimental burn wound sepsis. J Trauma 30 (1990) 737-740
105. Munster A.M., Xiao G.-X., Guo Y., Wong L.A., and Winchurch R.A. Control of endotoxemia in burn patients by use of polymyxin B. J Burn Care Rehabil 10 (1989) 327-330
106. Munster A.M., Winchurch R.A., Thupari J.N., and Ernst C.B. Reversal of postburn immunosuppression with low-dose polymyxin B. J Trauma 26 (1986) 995-998
107. Guo Y., Dickerson C., Chrest F.J., Adler W.H., Munster A.M., and Winchurch R.A. Increased levels of circulating interleukin 6 in burn patients. Clin Immunol Immunopathol 54 (1990) 361-371
108. Munster A.M., Smith-Meek M., Dickerson C., Winchurch R., and Translocation. Incidental phenomenon or true pathology?. Ann Surg 218 (1993) 321-327
109. Xiao G.-X., Chopra R.K., Adler W.H., Munster A., and Winchurch R.A. Altered expression of lymphocyte IL2 receptors in burned patients. J Trauma 28 (1988) 1669-1672
110. Hansbrough J.F., Zapata-Sirvent R., Peterson V.M., et al. Characterization of the immunosuppressive effect of burned tissue in an animal model. J Surg Res 37 (1984) 383-393
111. Jones E.B. Prophylactic anti-lipopolysaccharide freezedried plasma in major burns: a double blind controlled trial. Burns 21 (1995) 267-272
112. Aulick L.H., Wroczynski F.A., Madan E., and Mason A.D. Wound endotoxin is not a principal mediator of postburn hypermetabolism in rats. J Trauma 30 (1990) 457-462
113. Jackson M.G.D., Topley E., and Carson J.S. Primary excision and grafting of large burns. Ann Surg 152 (1960) 167-189
114. Janzekovic Z. A new concept in the early excision and immediate grafting of burns. J Trauma 10 (1970) 1103-1108
115. Burke J.F., Bondoc C.C., and Quinby W.C. Primary burn excision and immediate grafting: a method shortening illness. J Trauma 14 (1974) 389-395
116. Burke J.F., Quinby W.C., and Bondoc C.C. Primary excision and prompt grafting as routine therapy for the treatment of thermal burns in children. Surg Clin North Am 56 (1976) 477-494
117. Tompkins R.G., Remensnyder J.P., and Burke J.F. Significant reductions in mortality for children with burn injuries through the use of prompt eschar excision. Ann Surg 208 (1988) 577-585
118. Tompkins R.G., Burke J.F., Schoenfeld D.A., et al. Prompt eschar excision: a treatment system contributing to reduced burn mortality. Ann Surg 204 (1986) 272-281
119. Tompkins R.G., Hilton J.F., Burke J.F., et al. Increased survival after massive thermal injuries in adults: preliminary report using artificial skin. Crit Care Med 17 (1989) 734-740
120. Herndon D.N., Barrow R.E., and Rutan R.L. A comparison of conservative versus early excision. Ann Surg 209 (1989) 547-553
121. Stratta R., Warden G., and Ninneman J. Immunologic parameters in burned patients: effect of therapeutic interventions. J Trauma 26 (1986) 7-12
122. Fox C.L. Silver sulfadiazine-a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. Arch Surg 96 (1968) 184-188
123. Eldad A., Newman A., and Weinberg A. Silver sulfadiazine induced hemolytic anemia in G6PD-deficient burned patient. Burns 17 (1991) 430-432
124. Coffi H.H., and Bingham H.G. Leukopenia and silver sulfadiazine. J Trauma 22 (1982) 586-587
125. Fox C., Monafo W.W., and Ayvazian V.H. Topical chemotherapy for burns using cerium salts and silver sulfadiazine. Surg Gynecol Obstet 144 (1977) 668-672
126. Monafo W.W., Robinson H.N., and Yoshioka T. Lethal burns. Arch Surg 113 (1978) 397-401
127. Monafo W.W., Tandon S.N., and Ayvazian V.H. Cerium nitrate, a new topical antiseptic for extensive burns. Surgery 80 (1976) 465-473
128. Boeckx W., Focquet M., Cornelissen M., and Nuttin B. Bacteriological effect of cerium-fl amazine cream in major burns. Burns 11 (1985) 337-342
129. Monafo W.W., Ayvazian V.H., and Skinner A.M. Control of infection in major burn wounds by cerium nitrate/silver sulphadiazine. Burns 3 (1977) 104-107
130. Lorenz V, Specht U, Beyer W, Strohmann F, G. S., Mau H. Erfahrungen mit der Anwendung von Cerium-Nitrat- Silbersulfadiazin bei der Lokalbehandlung thermischer Verletzungen im Kindersalter. Zentralbl Chir 1988; 113:1273-9.
131. Wasserman D., Schlotterer M., Lebreton F., Levy J., and Guelfi M.C. Use of topically applied silver sulphadiazine plus cerium nitrate in major burns. Burns 15 (1989) 257-260
132. Marone P., Monzillo V., Perversi L., and Carretto E. Comparative in vitro activity of silver sulfadiazine, alone and in combination with cerium nitrate against staphylococci and Gram-negative bacteria. J Chemother 10 (1998) 17-21
133. Ross D.A., Phipps J.A., and Clarke J.A. The use of cerium nitratesilver sulphadizine as a topical burns dressing. Br J Plast Surg 46 (1993) 582-584
134. Monafo W.W., and Ayvazian V.H. Topical therapy. Surg Clin North Am 58 (1978) 1157-1171
135. Haley T.J. Pharmacology and toxicology of the rare earth elements. J Pharm Sci 54 (1965) 663-670
136. Herruzo-Cabrera R., Vizcaino-Alcaide M.J., Mayer R.F., and Rey- Calero J. A new in vitro model to test the effectiveness of topical antimicrobial agents. Use of an artificial eschar. Burns 18 (1992) 35-38
137. Herruzo-Cabrera R., Garcia-Torres V., Rey-Calero J., and Vizcaino-Alcaide M.J. Evaluation of the penetration strength, bactericidal efficacy and spectrum of action of several antimicrobial creams against isolated microorganisms in a burn centre. Burns 18 (1992) 39-44
138. Boeckx W., Blondeel P.N., and Vandersteen K. Effect of cerium nitrate-silver sulphadizine on deep dermal burns: a histological hypothesis. Burns 18 (1992) 456-462
139. de Gracia C.G. An open study comparing topical silver sulfadiazine and topical silver sulfadiazine-cerium nitrate in the treatment of moderate and severe burns. Burns 27 (2001) 67-74
140. Santos F.X., Sanchez-Gabriel J., Mayoral E., and Hamann C. Air evacuation of critically burned patients. Mil Med 160 (1995) 593-596
141. Garner J.P., and Heppell P.S.J. The use of flammacerium in British burns units. Burns 31 (2005) 379-382
142. Garner J.P., and Heppell P.S.J. Cerium nitrate in the management of burns. Burns 31 (2005) 539-547
143. Vehmeyer-Heeman M., Van Holder C., Nieman F., Vanden Kerckhove E., and Boeckx W. Predictors of mortality: a comparison between two burn wound treatment policies. Burns 33 (2007) 167-172
144. Pereira C., Barrow R.E., Sterns A.M., et al. Age-dependent differences in survival after severe burns: a unicentric review of 1,674 patients and 179 autopsies over 15 years. J Am Coll Surg 202 (2006) 536-548
145. Schoenenberger RA. In vitro and in vivo studies of the complexing of a specific cutaneous burn toxin by cerium nitrate. University of Basel: thesis; 1984.
146. Kistler D., Hafermann B., Schoenenberger G.A., and Hettich R. Increased survival rates by topical treatment of burns with cerium nitrate. Eur Surg Res 22 (1990) 283-290
147. Schoenenberger G.A., Kistler D., Klein P., and Allgower M. Experimental comparison of the effect of early excision vs topical cerium nitrate upon a late mortality with respect to cutaneous toxin absorption. Eur Surg Res 13 (1981) 64-65
148. Pietsch L.B., Meakins J.L., and Gotto D. Delayed hypersensitivity responses: the effect of surgery. J Surg Res 22 (1977) 228-232
149. Markely K., and Smallman E.T. Effect of burn trauma in mice on the generation of cytotoxic lymphocytes. Proc Soc Exp Biol Med 160 (1979) 468-472
150. Ninneman JL. Suppression of lymphocyte response following thermal injury. In: Ninneman JL, editor. The immune consequences of thermal injury. London, Baltimore MD: Williams & Wilkins; 1981, p. 66-91.
151. Peterson V.M., Hansbrough J.F., Wang X.W., Zapata-Sirvent R., and Boswick J.A. Topical cerium nitrate prevents postburn immunosuppression. J Trauma 25 (1985) 1039-1044
152. Hansbrough J.F., Peterson V., and Korz E. Postburn immunosuppression in an animal model: monocyte dysfunction induced by burned tissue. Surgery 93 (1983) 415-424
153. Echinard C.E., Sajdel-Sulkowska E., Burke P.A., and Burk J.F. The beneficial effect of early excision on clinical response and thymic activity after burn injury. J Trauma 22 (1982) 560-565
154. Hansbrough J.F., and Gadd M.A. Temporal analysis of murine lymphocyte subpopulations by monoclonal antibodies and dual-color flow cytometry after burn and nonburn injury. Surgery 106 (1989) 69-80
155. Deveci M., Eski M., Sengezer M., and Kisa U. Effects of cerium nitrate bathing and prompt burn wound excision on IL-6 and TNF-a levels in burned rats. Burns 26 (2000) 41-45
156. Scheidegger D., Sparkes B.G., Luscher N., Schoenenberger G., and Allgower M. Survival in major burn injuries treated by one bathing in cerium nitrate. Burns 18 (1992) 296-300
157. Sparkes B.G. Mechanisms of immune failure in burn injury. Vaccine 11 (1993) 504-510
158. Stadtler K, Schoenenberger GA. Application of the in vitro results to burn toxin formation in vivo. Immunological applications. In: Toxic factors in burns. University of London: European Research Office; 1976, p. 90-8.
159. Spies M., Herndon D.N., Sparkes B.G., and Allgower M. Skin toxicity induced by wet heat. Burns 29 (2003) 215-220
160. Spies M, Allgower M, Vogt PM, Sparkes BG. Toxicity of burned skin neutralized by cerium nitrate. Burns.(submitted).
161. Rachid A., Christophe M., Bertin-Maghit M., Laure O., Sylvie T., and Paul P. Methemoglobinemia by cerium nitrate poisoning. Burns 32 (2006) 1060-1061
162. Bull J.P., and Squire J.R. A study of mortality in a burns unit; standards for the evaluation of an alternative method of treatment. Ann Surg 130 (1949) 160-173
163. Bull J.P., and Fisher A.J. A study of mortality in a burns unit: a revised estimate. Ann Surg 139 (1954) 269-274
164. Sparkes B.G., and Allgöwer M. Nouvelles perspectives dans le traitement des brûlures. Brûlures 2 (2001) 12-21
165. Sturdevant JL, Herndon DN, Sparkes BG, et al. Improved survival of adult burn injuries-a multicenter evaluation. 33rd Annual Meeting. Boston MA: American Burn Association; 2001, Abstract 127.
166. Prasanna M., Mishra P., and Thomas C. Delayed primary closure of the burn wounds. Burns 30 (2004) 169-175
167. Vehmeyer-Heeman M., Tondu T., Vanden Kerckhove E., and Boeckx W. Application of cerium nitrate-silver sulphadizine allows for postponement of excision and grafting. Burns 32 (2006) 60-63
168. Allgower M. Centennial perspective on burn treatment. J Am Coll Surg 200 (2005) 814-815